The drug regulatory authority of China – National Medical Product Administration (NMPA, formerly CFDA) has recently implemented a possibility to report Adverse Drug Reactions (ADR) through an XML-file submission. Flex Databases Pharmacovigilance system users are already able to do so. There are two general ways of reporting to the regulator – manual submissions through the website and […]
Want to get the latest news on clinical trials?